GLOW

Description

GLOW 70mg — Dermal & Regenerative Research Blend

GLOW is a Phase One Labz multi-peptide research blend co-formulated for investigations into skin biology, tissue regeneration, and extracellular matrix remodeling. The blend combines GHK-Cu with complementary regenerative peptides in a single reconstitutable vial, enabling parallel study of synergistic pathways rather than single-peptide effects in isolation.

Mechanism of Action

The GLOW formulation couples GHK-Cu’s copper-dependent gene-expression modulation (collagen I/III, decorin, metalloproteinase pathways) with companion regenerative peptides that influence focal adhesion kinase signaling, VEGF-mediated angiogenesis, and fibroblast migration. The combination is of interest in research contexts where a single compound produces incomplete coverage of the matrix-remodeling cascade — GHK-Cu drives matrix protein synthesis while the co-peptides accelerate cell migration and capillary network formation.

Research Applications

• Dermal matrix synthesis and collagen remodeling
• Hair follicle stimulation and dermal papilla research
• Matrix remodeling and dermal-biology studies
• Photoaging and skin barrier recovery investigations
• Combined-peptide synergy vs single-compound controls
• Fibroblast migration and angiogenesis research

Product Specifications

• Total Content: 70mg blended per vial
• Purity: ≥99% each component (HPLC verified)
• Form: Lyophilized powder (co-formulated)
• Storage: Refrigerate after reconstitution
• Testing: Third-party lab tested, COA available on Portal
• Actual Tested Value: 73.97 mg

For research purposes only. Not for human or veterinary use.